Home › Essential Thrombocythemia › California › Mountain View
Essential Thrombocythemia clinical trials in Mountain View, CA
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Stanford Cancer Center, Palo Alto · 5 mi away
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Stanford University, Palo Alto · 5 mi away
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Stanford Cancer Institute, Palo Alto · 5 mi away
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Baltimore, MD4 studies
- Nashville, TN4 studies
- Salt Lake City, UT4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Irvine, CA3 studies
- Columbus, OH3 studies
- St. Louis, MO3 studies
- Los Angeles, CA3 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer25 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Heart Failure15 studies
- Prostate Cancer15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.